[1]
|
Wang X M,Peng W,Li C,et al. Identification of an immune-related signature indicating the dedifferentiation of thyroid cells[J]. Cancer Cell Int,2021,21(1):231. doi: 10.1186/s12935-021-01939-3
|
[2]
|
Tiedje V,Stuschke M,Weber F,et al. Anaplastic thyroid carcinoma:Review of treatment protocols[J]. Endocr Relat Cancer,2018,25(3):R153-R161. doi: 10.1530/ERC-17-0435
|
[3]
|
Buergy D,Wenz F,Groden C,et al. Tumor-platelet interaction in solid tumors[J]. Int J Cancer,2012,130(12):2747-2760. doi: 10.1002/ijc.27441
|
[4]
|
Palacios-Acedo A L,Mège D,Crescence L,et al. Platelets,thrombo-inflammation,and cancer:Collaborating with the enemy[J]. Front Immunol,2019,10:1805. doi: 10.3389/fimmu.2019.01805
|
[5]
|
Rothwell P M,Wilson M,Price J F,et al. Effect of daily aspirin on risk of cancer metastasis:A study of incident cancers during randomised controlled trials[J]. Lancet,2012,379(9826):1591-1601. doi: 10.1016/S0140-6736(12)60209-8
|
[6]
|
Haemmerle M,Stone R L,Menter D G,et al. The platelet lifeline to cancer:Challenges and opportunities[J]. Cancer Cell,2018,33(6):965-983. doi: 10.1016/j.ccell.2018.03.002
|
[7]
|
Schlesinger M. Role of platelets and platelet receptors in cancer metastasis[J]. J Hematol Oncol,2018,11(1):125. doi: 10.1186/s13045-018-0669-2
|
[8]
|
Xu X R,Yousef G M,Ni H. Cancer and platelet crosstalk:Opportunities and challenges for aspirin and other antiplatelet agents[J]. Blood,2018,131(16):1777-1789. doi: 10.1182/blood-2017-05-743187
|
[9]
|
Leblanc R,Peyruchaud O. Metastasis:New functional implications of platelets and megakaryocytes[J]. Blood,2016,128(1):24-31. doi: 10.1182/blood-2016-01-636399
|
[10]
|
Takemoto A,Takagi S,Ukaji T,et al. Targeting podoplanin for the treatment of osteosarcoma[J]. Clin Cancer Res,2022,28(12):2633-2645. doi: 10.1158/1078-0432.CCR-21-4509
|
[11]
|
Suzuki-Inoue K. Platelets and cancer-associated thrombosis:Focusing on the platelet activation receptor CLEC-2 and podoplanin[J]. Blood,2019,134(22):1912-1918. doi: 10.1182/blood.2019001388
|
[12]
|
Shang Y,Sun J,Wu X,et al. Activated platelet membrane nanovesicles recruit neutrophils to exert the antitumor efficiency[J]. Front Chem,2022,10:955995. doi: 10.3389/fchem.2022.955995
|
[13]
|
Li Q,Mo W,Ding Y,et al. Study of lncRNA TPA in promoting invasion and metastasis of breast cancer mediated by TGF-β signaling pathway[J]. Front Cell Dev Biol,2021,9:688751. doi: 10.3389/fcell.2021.688751
|
[14]
|
Li Y,Zhou X,Liu J,et al. Dihydroartemisinin inhibits the tumorigenesis and metastasis of breast cancer via downregulating CIZ1 expression associated with TGF-β1 signaling[J]. Life Sci,2020,248:117454. doi: 10.1016/j.lfs.2020.117454
|
[15]
|
Ren Y,Jia H H,Xu YQ,et al. Paracrine and epigenetic control of CAF-induced metastasis:The role of HOTAIR stimulated by TGF-ß1 secretion[J]. Mol Cancer,2018,17(1):5. doi: 10.1186/s12943-018-0758-4
|